MS - 1.0043.0760
Farm. Resp.: Dra. Sônia Albano Badaró - CRF-SP 19.258
Marca registrada sob licença de:
ALMIRALL S.A.
Barcelona Espanha
Registrado por:
EUROFARMA LABORATÓRIOS S.A.
Av. Vereador José Diniz, 3.465 - São Paulo - SP
CNPJ: 61.190.096/0001-92
Indústria Brasileira
Solução Oral:
Fabricado por:
EUROFARMA LABORATÓRIOS S.A.
Rod. Pres. Castelo Branco, km 35,6 Itapevi SP
LOGO CENTRAL DE ATENDIMENTO EUROFARMA COM TEL 0800 704 3876.
Venda sob prescrição médica.
Referências bibliográficas
1Ratner PH, Lim JC, Georges GC, and the Ebastine Study Group. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. Allergy Clin Immunol2000;105:1101-7.
2Ostrom N, Welch M, Morris R, et al. Evaluation of ebastine (Eba), a new non-sedating antihistamine in children with seasonal allergic rhinitis (SAR) [abstract no. 261586]. J Allergy Clin Immunol 1994; 93 (1 Pt 2):
163APUD Hurst M & Spencer CM. Ebastine, An Update of its Use in Allergic Disorders. Drugs 2000; 59: 981- 1006.
3Luria X. Comparative Clinical Studies with Ebastine. Efficacy and Tolerability. Drug Safety 1999; 21 Suppl. 1:63-7.
4Sastre J. Ebastine in allergic rhinitis and chronic idiopathic urticaria. Allergy 2008: 63 (89): 120.